Hepatotoxicity and toxicokinetics of ketoconazole in rabbits

Acta Pharmacologica Sinica

Volumn 24, Issue 8, 2003, Pages 778-782

  Ma, Yue Ming ^a   Ma, Zhang Qing ^b   Gui, Chang Qing ^b   Yao, Jian She ^b   Sun, Rui Yuan ^b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b WANNAN MEDICAL COLLEGE   (China)

Author keywords

Hepatotoxicity; Ketoconazole; Pharmacokinetics

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIFUNGAL AGENT; ASPARTATE AMINOTRANSFERASE; DIAZEPAM; KETOCONAZOLE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIVER; LIVER TOXICITY; MALE; METABOLISM; NONHUMAN; RABBIT; TOXICOKINETICS;

ALANINE TRANSAMINASE; ANIMALS; ANTIFUNGAL AGENTS; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; FEMALE; KETOCONAZOLE; LIVER; MALE; RABBITS;

EID: 0042735038     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Stricker BH, Blok AP, Bronkhorst FB, Van Parys GE, Desmet VJ. Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol 1986; 3: 399-406.
2. Jacobson MA, Hanks DK, Ferrell LD. Fatal acute hepatic necrosis due to fluconazole. Am J Med 1994; 96: 188-90.
3. Lavrijsen APM, Balmus KJ, Nugtem-Huying WM, Robdaan AC, van't Wout JW, Stricker BHC. Hepatic injury associated with itraconazole. Lancet 1992; 340: 251-2.
4. Garcia Rodriguez LA, Duque A, Castellsague J, Perez-Gutthann S, Stricker BH. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol 1999; 48: 847-52.
5. Fu HG, Zhang T. Acute hepatic failure-induced death due to ketoconazole. Adverse Drug Reactions J 2001; 3: 159.
6. Deng PY. Ketoconazole and hepatotoxic damage. Chin Pharm Affair 1995; 9: 49-51.
7. Findor JA, Sorda JA, Igartua EB, Avagnina A. Ketoconazole-induced liver damage. Medicina (B Aires) 1998; 58: 277-81.
8. Lake-Bakaar G, Scheuer PJ, Sherlock S. Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J 1987; 294: 419-22.
9. Whitehouse LW, Menzies A, Dawson B, Zamecnik J, Sy WW. Deacetylated ketoconazole: a major ketoconazole metabolite isolated from mouse liver. J Pharm Biomed Anal 1990; 8: 603-6.
10. Rodriguez RJ, Acosta D Jr. Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases. Drug Metab Dispos 1997; 25: 772-7.
11. Rodriguez RJ, Acosta D. N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. Toxicology 1997; 117: 123-31.
12. Rodriguez RJ, Miranda CL. Isoform specificity of N-deacetyl ketoconazole by human and rabbit flavin-containing monooxygenases. Drug Metab Dispos 2000; 28: 1083-6.
13. Sun RY, Ma YM, Hong ZY. Design of pharmacological experiment and statistic analysis. In: Xu SY, Bian RL, Chen X. Methodology of pharmacological experiment. 3rd ed. Beijing: People's Medical Publishing House; p195-223.
14. Odriguez RJ, Proteau PJ, Marquez BL, Hetherington CL, Buckholz CJ, O'Connell KL. Flavin-containing monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes. Drug Metab Dispos 1999; 27: 880-6.
15. Lemoine A, Williams DE, Cresteil T, Leroux JP. Hormonal regulation of microsomal flavin-containing monooxygenase: tissue-dependent expression and substrate specificity. Mol Pharmacol 1991; 40: 211-7.
16. Cherrington NJ, Cao Y, Cherrington JW, Rose RL, Hodgson E. Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3, and 5. Xenobiotica 1998; 28: 673-82.
17. Sjoberg P, Ekman L, Lundqvist T. Dose and sex-dependent disposition of ketoconazole in rats. Arch Toxicol 1988; 62: 177-80.
18. Huang YC, Colaizzi JL, Bierman RH, Woestenborghs R, Heykants J. Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers. Antimicrob Agents Chemother 1986; 30: 206-10.